Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-0005-2025

Drug recall · October 9, 2024

Veklury recall

Why: Presence of Particulate Matter: Presence of glass particle.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Lots / codes

Lot: 47035CFA, Exp. 11/2025

Quantity
105,000 vials
Company
Gilead Sciences, Inc., Foster City, CA
Distribution
Nationwide in the U.S.A.
Initiated
September 19, 2024 · Voluntary: Firm initiated
Classified
October 3, 2024
Reported
October 9, 2024
Ended
July 29, 2025
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.